We identify a deletion causing FOXC1 to gain an eQTL and enhancer in pancreatic cancer, and a duplication resulting in a gain of an eQTL for BCL6 in colorectal cancer. The gene discussed is FOXC1; the disease is familial pancreatic carcinoma.